SCHEMBL7159257

SCHEMBL7159257

CN(CCc1cc2ccccc2[nH]1)Cc1ccc(-c2nc3cccc4c3n2CCNC4=O)cc1

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7159335 0.84 PARP1 (0.75) PARP1
SCHEMBL7163790 0.84 PARP1 (0.83) PARP1
SCHEMBL7160943 0.84 PARP1 (0.71) PARP1
SCHEMBL6196282 0.81 PARP1 (1.00) PARP1
SCHEMBL7165697 0.80 PARP1 (0.79) PARP1
SCHEMBL7164353 0.79 PARP1 (0.81) PARP1
SCHEMBL7160474 0.78 PARP1 (0.78) PARP1
SCHEMBL7162352 0.77 PARP1 (0.73) PARP1
SCHEMBL12231979 0.76 PARP1 (0.80) PARP1
SCHEMBL7164457 0.76 PARP1 (0.66) PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6548494-B1 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases AGOURON PHARMACEUTICALS, INC. 2003-04-15 US disclosed